30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
Jewelry Retailer Told Applicant She Was Too Old, Federal Agency Charges - KETCHIKAN, Alaska - SAI ...
Read More >
Courts and arbitral tribunals in many jurisdictions have the power to order contractors to perform b...
Read More >
On December 18, 2019 New York State’s Department of Health (DOH) issued a Request for Offers (RFO) ...
Read More >
SMALL BUSINESS PROGRAMS & ADVISORY SERVICES - Small Business Administration – The SBA issued a pr...
Read More >
The cannabis industry is booming. Legal pot is now a more than $10 billion industry in the United St...
Read More >
The Department of Labor (DOL) published a Notice of Proposed Rulemaking (NPRM) on October 8, 2019, t...
Read More >